C07D 295/08
Substituted by singly bound oxygen or sulfur atoms
Official title: substituted by singly bound oxygen or sulfur atoms
C07D295/08 (Substituted by singly bound oxygen or sulfur atoms) appears on 2,632 US grants and 1,744 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,632
- Published applications
- 1,744
- Assignees
- 1,121
- Inventors
- 6,814
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 80 | 0 |
| 1977 | 74 | 0 |
| 1978 | 74 | 0 |
| 1979 | 46 | 0 |
| 1980 | 52 | 0 |
| 1981 | 66 | 0 |
| 1982 | 61 | 0 |
| 1983 | 60 | 0 |
| 1984 | 42 | 0 |
| 1985 | 52 | 0 |
| 1986 | 52 | 0 |
| 1987 | 42 | 0 |
| 1988 | 53 | 0 |
| 1989 | 51 | 0 |
| 1990 | 49 | 0 |
| 1991 | 44 | 0 |
| 1992 | 50 | 0 |
| 1993 | 33 | 0 |
| 1994 | 45 | 0 |
| 1995 | 38 | 0 |
| 1996 | 43 | 0 |
| 1997 | 53 | 0 |
| 1998 | 48 | 0 |
| 1999 | 55 | 0 |
| 2000 | 41 | 0 |
| 2001 | 67 | 11 |
| 2002 | 77 | 65 |
| 2003 | 55 | 92 |
| 2004 | 58 | 111 |
| 2005 | 68 | 110 |
| 2006 | 60 | 87 |
| 2007 | 51 | 76 |
| 2008 | 62 | 68 |
| 2009 | 59 | 88 |
| 2010 | 58 | 88 |
| 2011 | 57 | 77 |
| 2012 | 50 | 53 |
| 2013 | 59 | 60 |
| 2014 | 54 | 90 |
| 2015 | 52 | 78 |
| 2016 | 67 | 66 |
| 2017 | 60 | 68 |
| 2018 | 44 | 59 |
| 2019 | 41 | 51 |
| 2020 | 38 | 61 |
| 2021 | 45 | 64 |
| 2022 | 35 | 62 |
| 2023 | 40 | 50 |
| 2024 | 30 | 46 |
| 2025 | 24 | 40 |
| 2026 | 17 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Phenolic acid lipid based cationic lipids29 Sep 2026US 12,747,198 B2Translate Bio, Inc.
- Method for preparation of 1-(2-((2,4-dimethylphenyl)thio)phenyl) piperazine and its salts29 Sep 2026US 12,747,220 B2R L Finechem Private Limited
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Amino acid-based cationic lipid3 Sep 2026US 2026/0257986 A1Xiamen Sinopeg Biotech Co., Ltd.
- Nanomaterials containing constrained lipids and uses thereof13 Aug 2026US 2026/0232587 A1Georgia Tech Research Corporation
- Triarylsulfonium based photoinitiators for led cure of cationic, free radical and hybrid cationic/free radical formulations6 Aug 2026US 2026/0226018 A1Arkema France
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
- Autophagy inducing compounds and uses thereof9 Jul 2026US 2026/0193180 A1
Most cited
By later US patents
- 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents381US 4,133,814 AEli Lilly and Company · 1979
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999